* NU Skin Enterprises Inc NUS.N NUS is expected to show
a fall
in quarterly revenue when it reports results on February 16.
* The Provo Utah-based company is expected to report a
12.3% decrease in revenue to $655.934 million from $748.19
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NU Skin Enterprises
Inc
is for earnings of 95 cents per share. For the same quarter last
year, the company reported earnings of $1.40 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NU Skin
Enterprises Inc is $60, about 16.7% above its last closing
price of $50.01.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.88 0.86 0.97 Beat 12.9
Jun. 30 2021 1.06 1.05 1.15 Beat 10
Mar. 31 2021 0.73 0.72 0.91 Beat 26
Dec. 31 2020 1.18 1.19 1.40 Beat 17.9
Sep. 1.03 0.98 1.08 Beat 10.7
30 2020
Jun. 30 2020 0.69 0.62 0.81 Beat 30.5
Mar. 31 2020 0.25 0.25 0.36 Beat 42.6
Dec. 31 2019 0.72 0.72 0.72 Met 0.3
This summary was machine generated February 14 at 13:59 GMT.
All figures in US dollars unless otherwise stated